Publications (42) Publications auxquelles un chercheur a participé

2010

  1. Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

    Blood, Vol. 116, Núm. 8

  2. Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: Implications for antiangiogenic/antithrombotic strategies

    British Journal of Dermatology, Vol. 162, Núm. 2, pp. 350-356

  3. Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis

    Cancer Gene Therapy, Vol. 17, Núm. 1, pp. 20-27

  4. Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells

    PLoS ONE, Vol. 5, Núm. 12

  5. Bemiparin in oncology

    Drugs, Vol. 70, Núm. SUPPL. 2, pp. 35-42

  6. Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and-resistant Bcr-Abl1-expressing cells

    Oncogene, Vol. 29, Núm. 22, pp. 3276-3286

  7. Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: A randomised trial

    The Lancet Oncology, Vol. 11, Núm. 10, pp. 934-941

  8. Cardiomyocyte differentiation of rat bone marrow multipotent progenitor cells is associated with downregulation of Oct-4 expression

    Tissue Engineering - Part A, Vol. 16, Núm. 10, pp. 3111-3117

  9. Cardiotoxicidad por adriamicina: ¿existen alternativas eficaces para su prevención?

    Medicina Clinica, Vol. 134, Núm. 2, pp. 70-71

  10. Characterization of coronary plaques with combined use of intravascular ultrasound, virtual histology and optical coherence tomography

    Heart International, Vol. 5, Núm. 2, pp. 58-63

  11. Circulating human b and plasma cells. age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138 plasma cells

    Haematologica, Vol. 95, Núm. 6, pp. 1016-1020

  12. Clinical applications of reporter gene technology

    Molecular Imaging with Reporter Genes (Cambridge University Press), pp. 297-314

  13. Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry

    Thrombosis Research, Vol. 126, Núm. 4, pp. 283-286

  14. Corrigendum to "Preliminary characterisation of the promoter of the human p22phox gene: Identification of a new polymorphism associated with hypertension" [FEBS Lett. 542 (2003) 27-31]

    FEBS Letters

  15. DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia

    PLoS ONE, Vol. 5, Núm. 8

  16. Enhanced sensitivity of flow cytometry for routine assessment of minimal residual disease

    Haematologica

  17. Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia

    Cancer Science, Vol. 101, Núm. 2, pp. 425-432

  18. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

    Leukemia

  19. Gene therapy: A pharmacokinetic/pharmacodynamic modelling overview

    Pharmaceutical Research, Vol. 27, Núm. 8, pp. 1487-1497

  20. Human peripheral blood B-Cell compartments: A crossroad in B-cell traffic

    Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. SUPPL. 1